Sechenov University and Akrikhin Russian Pharmaceutical Company
Signing of a protocol of intent on further cooperation to jointly develop and invest in the creation of innovative Russian medicines for the treatment of type 2 diabetes mellitus and other metabolic disorders.
Representatives of the parties signing the agreement
Vadim Tarasov,
Head of Innovative Pharmaceuticals; Director of the Institute of Translational Medicine and Biotechnology, Sechenov University
Denis Chetverikov,
President, Akrikhin Russian Pharmaceutical Company